First time available for research use

CTLA4 | CD152-antibody

Ipilimumab antibody from Yervoy®

NEW ! Available with Certificate of Analysis (CoA)

Therapeutic CTLA4 | CD152-antibody from the original Yervoy® commercial drug targeting the CTLA4-antigen, also referred to as Yervoy® or Ipilimumab antibody. Research-relevant quantities are available as licence-free consumable in aliquoted or diluted variant. Therapeutic monoclonal antibodies can be used from researchers in in vitro and in vivo experiments, biosimilar developers can order different batches at the same time.

NEW: This product is available with the original manufacturer’s Certificate of Analysis (CoA)!

Choose your antibody
CTLA4 | CD152-antibody-Ipilimumab
Easy Access

Easy Access

Easy to order as license-free research consumable
Multiple batches

Multiple batches

Up to 10 batches of original drugs for examining batch-to-batch variations
Reduce costs

Reduce costs

Up to 80% less compared to the original pharmaceutical price
Prompt delivery

Prompt delivery

Shipment within days worldwide according to GDP-standards
Documented origin

Documented origin

Information on batch, registration number, expiry date, GDP-compliant pedigree

What our clients say

Product Reference